PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Sep-2025 Aro Biotherapeutics Completes Enrollment in Phase 1b Trial of Targeted siRNA Therapy, ABX1100, in Late-Onset Pompe Disease (LOPD) Businesswire
24-Sep-2025 Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome Businesswire
24-Sep-2025 TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors Businesswire
24-Sep-2025 Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA® and FILRA® Biosimilars in Canada Businesswire
24-Sep-2025 Accellix, Inc. and Streck Collaborate to Advance Cell Therapy with Quality Control Businesswire
24-Sep-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
24-Sep-2025 TruMerit and EnGen Partner to Equip Foreign-Educated Health Professionals With English Skills for Success in Work and Life ACCESS Newswire
24-Sep-2025 Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9) Businesswire
24-Sep-2025 Europe Activated Carbon for Water Treatment Research Report 2025-2035: Competitive Analysis of Jacobi Carbons, Silcarbon Aktivkohle, Norit, CarboTech AC, Donau Carbon, and Desotec - ResearchAndMarkets.com Businesswire
24-Sep-2025 Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases Businesswire
24-Sep-2025 Europe Flow Cytometry Market Analysis and Forecast Report 2025-2035: Rising Demand for Compact, Benchtop Flow Cytometers Suitable for Decentralized Labs and Point-of-care Settings - ResearchAndMarkets.com Businesswire
24-Sep-2025 Microbiotica Announces Completion of Recruitment in its International Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Microbiotica
24-Sep-2025 Major Shareholder Announcement Genmab
24-Sep-2025 Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System Miocrbot Medical®
24-Sep-2025 OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain OKYO Pharma
24-Sep-2025 Availability of the Q3 2025 Aide mémoire Sanofi
24-Sep-2025 Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Sanofi
24-Sep-2025 Cambridge Network launches Graduate Scheme to develop future leaders Cambridge Network
24-Sep-2025 Steriwave Now Protecting Patients with Cancer Steriwave
24-Sep-2025 YPrime Releases Inaugural ESG Report, Reinforcing Commitment to Responsible Innovation in Clinical Research YPrime